Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ying-Pi No.1
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital, Zhejiang University School of Medicine
- Administration
- Topical
01
Overview
Ying-Pi No.1 appears to be a topical product, specifically a hand mask cream, that has been studied for the treatment of scleroderma in at least one clinical trial in China[7]. The name "Ying Pi" (樱皮) refers to Japanese cherry bark (Prunus serrulata), which is used in Traditional Chinese Medicine (TCM) as an herb that clears heat and relieves toxicity, with actions such as expelling pus, relieving fevers, descending Lung Qi, and stopping coughing[1][2][3]. However, it is unclear if the hand mask cream contains Japanese cherry bark or if "Ying-Pi" here refers to another formulation or proprietary blend for dermatological use. There is no evidence from available sources that this product is a pharmaceutical drug; rather it seems to be a TCM-based topical preparation.
- Brand names
- Ying-Pi No.1
Beyond the preview
Go deeper on Ying-Pi No.1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ying-Pi No.1.